Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Clinical trial NCT01297400 · RECRUITING
Trial details
- NCT number
- NCT01297400
- Sponsor
- Skingenix, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-11
- Primary completion
- 2026-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.